Hepatitis C Virus (HCV) NS5A Drug Resistance Assay (LabCorp) Build info

Synonyms

  • HEPATITIS C VIRUS NS5A DRUG RESISTANCE
  • HEPCNS5A
  • LAB11829

Short Name

HEPATITIS C VIRUS NS5A DRUG RESISTANCE

Procedure Master Number

LAB11829

Procedure ID

115899

Clinical Info

Assessment of drug susceptibility by nucleic acid sequencing of a patient's hepatitis C virus (HCV) to the NS5A inhibitors. Assay should be used for patients with documented HCV genotype 1.

Specimen Type

Container

Lavender Top Tube

Collection Instructions

Container/Tube: PPT™ tubes or Lavender (EDTA) tube
Specimen: 2 mL Plasma ( 1 mL min)
Transport Temperature: Frozen plasma
 
Note: Centrifuge specimen within six hours of collection, remove plasma, transfer specimen to polypropylene screw-capped tubes, and freeze. Specimens drawn into PPT™ tubes need to be centrifuged within six hours and frozen.
 
Limitations This procedure may not be successful when the HCV viral load is <500 IU/mL. This assay requires an HCV genotype of either 1a or 1b
 

Transport Instructions

Frozen plasma

Specimen Stability

Methodology

Polymerase chain reaction (PCR) amplification and DNA next generation sequencing

Days Performed

TEST DELAY Current TAT 19-23 Days
TAT: 11-15 Days

Performing Laboratory

LabCorp-Monogram Bioscience

CPT

87900
87902

PDM

1659077

Results
Component Name Base Name Common Name External Name
HCV NS5A DRUG RESISTANCE HCVNS5A HCV NS5A DRUG RESISTANCE Hcv Ns5A Drug Resistance
HCV NS5A RESIST ASSAY INTERP HCVNS5A HCV NS5A RESIST ASSAY INTERP Hcv Ns5A Resist Assay Interp
HCV NS5A RESISTANCE ASSAY PDF HCVNS5A HCV NS5A RESISTANCE ASSAY PDF Hcv Ns5A Resistance Assay Pdf